Late overall morbidity (after the first 30 postoperative days: within 6 months) · patients with sigmoid diverticulitis
It is very uncertain whether laparoscopic changes late overall morbidity (after the first 30 postoperative days:… compared with open surgery (very low certainty).
1 finding from 1 review
Late overall mortality (after the first 30 postoperative days) · patients with sigmoid diverticulitis
It is very uncertain whether laparoscopic changes late overall mortality (after the first 30 postoperative days) compared with open surgery (very low certainty).
1 finding from 1 review
Major complications · patients with sigmoid diverticulitis
Laparoscopic showed no clear difference in major complications ( compared with open surgery (low certainty).
1 finding from 1 review
Minor complications (3 to 6 weeks · patients with sigmoid diverticulitis
1 finding from 1 review
Operating time · patients with sigmoid diverticulitis
1 finding from 1 review
Intervention not reported
Time to first flatus Hours · individuals undergoing abdominal surgery
1 finding from 1 review
Intervention not reported
Time to first bowel movement Hours · individuals undergoing abdominal surgery
1 finding from 1 review
Intervention not reported
Length of hospital stay Days · individuals undergoing abdominal surgery
1 finding from 1 review
Intervention not reported
Time to first bowel sounds Hours · individuals undergoing abdominal surgery
1 finding from 1 review
Intervention not reported
Complications Frequency · individuals undergoing abdominal surgery
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Tolerability of gum Anecdotal evidence, interviews, questionnaires and surveys · individuals undergoing abdominal surgery
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Cost · individuals undergoing abdominal surgery
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Overall survival (3 years) · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
It is very uncertain whether combination chemotherapy changes overall survival (3 years) compared with single‐agent chemotherapy (very low certainty).
1 finding from 1 review
Disease-free survival · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
It is very uncertain whether combination chemotherapy changes disease‐free survival (3 years) compared with single‐agent chemotherapy (very low certainty).
1 finding from 1 review
Complete response rate after preoperative chemoradiation (ypCR) · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
Combination chemotherapy leads to higher complete response rate after preoperative chemoradiation (ypCR) compared with single‐agent chemotherapy (high certainty).
1 finding from 1 review
Toxicity ‐ early adverse events G3/4 · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
Combination chemotherapy probably leads to higher toxicity ‐ early adverse events G3/4 compared with single‐agent chemotherapy (moderate certainty).
1 finding from 1 review
Metastases intra‐abdominal · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
Combination chemotherapy showed no clear difference in metastases intra‐abdominal compared with single‐agent chemotherapy (moderate certainty).
1 finding from 1 review
Radiotherapy compliance · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
Combination chemotherapy probably leads to lower radiotherapy compliance compared with single‐agent chemotherapy (moderate certainty).
1 finding from 1 review
Chemotherapy compliance · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
Combination chemotherapy leads to lower chemotherapy compliance compared with single‐agent chemotherapy (high certainty).
1 finding from 1 review
Recurrence · patients with anorectal fistula
Radiofrequency showed no clear difference in recurrence compared with conventional fistula surgery (low certainty).
1 finding from 1 review